CHARACTERISTICS AND PREGNANCY OUTCOMES OF IN VITRO FERTILIZATION CASES WITH VAGINAL BLEEDING IN THE FIRST 12 WEEKS
Main Article Content
Abstract
Objective: To describe the clinical characteristics, serum progesterone levels, and evaluate the correlation between these factors and pregnancy outcomes in In Vitro Fertilization (IVF) patients experiencing vaginal bleeding in the first 12 weeks at the National Center for Reproductive Support.
Subjects and Methods: A prospective descriptive observational study conducted on 67 IVF patients with vaginal bleeding symptoms during the first 12 weeks of pregnancy, monitored from 07/2024 to 04/2025.
Results: A total of 67 IVF pregnancies complicated by vaginal bleeding during the first 12 weeks were included in the study. The mean maternal age was 31.85 ± 5.00 years, and the prevalence of overweight/obesity in the study population was 41.79%. Mild vaginal bleeding accounted for 94.03% of cases. Subchorionic hematoma detected on ultrasound was common, with a prevalence of 70.15%. The mean serum progesterone level in the study group was 57.59 ± 31.98 nmol/L. Among the patients, 5.97% had progesterone levels below 15 nmol/L, 23.88% had levels between 15–30 nmol/L, and 70.15% had levels above 30 nmol/L. Serum progesterone levels were associated with first-trimester pregnancy outcomes..
Conclusion: Vaginal bleeding during the first trimester in IVF pregnancies is a common symptom, most frequently presenting as mild bleeding. The mean serum progesterone level in the study population was 57.59 ± 31.98 nmol/L.
Article Details
Keywords
vaginal bleeding, in vitro fertilization (IVF), progesterone, subchorionic hematoma, pregnancy outcome.
References
[2] Nguyễn Đức Anh, Đặng Thị Minh NGuyệt. Nghiên cứu kêt quả dọa sảy thai trong 12 tuần đầu sau chuyển phôi đông lạnh tại Bệnh Viện Phụ Sản Trung Ương, 2018.
[3] Nielsen JM, Humaidan P, Jensen MB, Alsbjerg. Early pregnancy bleeding after assisted reproductive technology: a systematic review and secondary data analysis from 320 patients undergoing hormone replacement therapy frozen embryo transfer.,2023 Dec 4;38(12):2373-2381 doi: 10.1093/humrep/dead218
[4] Alsbjerg B, Jensen MB, Povlsen BB, Elbaek HO, Laursen RJ, Kesmodel US, Humaidan P.Hum Reprod. Rectal progesterone administration secures a high ongoing pregnancy rate in a personalized Hormone Replacement Therapy Frozen Embryo Transfer (HRT-FET) protocol: a prospective interventional study.. 2023 Nov 2;38(11):2221-2229. doi: 10.1093/humrep/dead185
[5] Álvarez M, Gaggiotti-Marre S, Martínez F, Coll L, García S, González-Foruria I, Rodríguez I, Parriego M, Polyzos NP, Coroleu B.Hum Reprod. Individualised luteal phase support in artificially prepared frozen embryo transfer cycles based on serum progesterone levels: a prospective cohort study. 2021 May 17;36(6):1552-1560. doi: 10.1093/humrep/deab031
[6] Alsbjerg B, Jensen MB, Povlsen BB, Elbaek HO, Laursen RJ, KesmodelUS, Humaidan P. Rectal progesterone administration secures a high ongoing pregnancy rate in a personalized Hormone Replacement Therapy Frozen Embryo Transfer (HRT-FET) protocol—aprospective interventional study. Hum Reprod 2023;dead195. https://doi.org/10.1093/humrep/dead185.
[7] Dantas ZN, Singh AP, Karachalios P, Asch RH, Balmaceda JP, Stone SC. Vaginal bleeding and early pregnancy outcome in an infertile population. J Assist Reprod Genet 1996;13:212–215.
[8] Wong PC, Qiao J, Ho C, Ramaraju GA, Wiweko B, Takehara Y, Nadkarni PV, Cheng LC, Chen HF, Suwajanakorn S, Vuong TN; Asia Pacific Fertility Advisory Group. Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective..Reprod Biomed Online. 2011 Jul;23(1):81-90. doi: 10.1016/j.rbmo.2011.03.023. Epub 2011 Apr 3.PMID: 21550853
[9] Farhi A, Reichman B, Boyko V, Hourvitz A, Ron-El R, Lerner-Geva L. Maternal and neonatal health outcomes following assisted reproduction. Reprod Biomed Online 2013;26:454–461.
[10] Healy DL, Breheny S, Halliday J, Jaques A, Rushford D, Garrett C, Talbot JM, Baker HWG. Prevalence and risk factors for obstetric
haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia. Hum Reprod 2010;25:265–274.
[11] Harville EW, Wilcox AJ, Baird DD, Weinberg CR. Vaginal bleeding in very early pregnancy. Hum Reprod 2003;18:1944–1947.
[12] Hasan R, Baird DD, Herring AH, Olshan AF, Funk MLJ, Hartmann KE. Association between first trimester vaginal bleeding and miscarriage. Obstet Gynecol 2009;114:860–867.
[13] Hasan R, Baird DD, Herring AH, Olshan AF, Funk MLJ, Hartmann KE. Patterns and predictors of vaginal bleeding in the first trimester of pregnancy. Ann Epidemiol 2010;20:524–531.
[14] Hofman G, Gundrum CL, Drake LM, Bertsche AB. Frequency and effect of vaginal bleeding on pregnancy outcome during the first
3 weeks after positive B-hCG test results following IVF-ET. FertilSteril 2000;74:609–613.
[15] Maman E, Lunenfeld E, Levy A, Vardi H, Potashnik G. Obstetric outcome of singleton pregnancies conceived through in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 1998;70:240–245.